In addition to Thomas Wilder, one other ELGX executive reported Sell trades in the last month.
The company has a one-year high of $26.50 and a one-year low of $5.20. Currently, Endologix Inc has an average volume of 239.17K.
One of the top 25 analysts, according to TipRanks.com, recently recommended Hold ELGX with a $6 price target.
Thomas Wilder’s trades have generated a -6.6% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.